Specialty Rheumatology
-
Featured
First Classification Criteria Developed for IgG4–Related Disease
The American College of Rheumatology and the European League Against Rheumatism that includes Massachusetts General Hospital physicians have developed and validated classification criteria for IgG4–related disease in a large cohort of patients.
-
Electronic Consultations Help Sustain Outpatient Care During the COVID-19 Pandemic
In the first months of the COVID-19 pandemic in Massachusetts, clinician-to-clinician electronic consultations at Massachusetts General Hospital increased substantially relative to in-person consultations.
-
Risk of Respiratory Failure Tripled in COVID-19 Patients with Existing Rheumatic Disease
Massachusetts General Hospital clinicians find that patients with rheumatic disease who develop COVID-19 need close monitoring.
-
Innovative Zebrafish Model Allows Visualization of Response to Cancer Drugs Over Time at Single-Cell Level and Leads to New Clinical Trial
Zebrafish generated by Massachusetts General Hospital Cancer Center and Massachusetts General Hospital's Department of Pathology researchers remain immunodeficient into adulthood and are transparent, allowing direct visualization of individual cells and their response to cancer therapy over time.
-
The Role of Atypical Chemoattractant Receptors in Recruiting Neutrophils into Inflamed Tissue Sites
In a mouse model of inflammatory arthritis, atypical chemoattractant receptors interact with classical signaling chemoattractant receptors to control distinct steps in the recruitment of neutrophils into tissue.
-
Tissue-Specific Contrast Agents for Optical Fluorescence to Evaluate Rheumatoid Arthritis
Using near-infrared contrast agents developed at Massachusetts General Hospital, researchers successfully conduct optical fluorescence imaging to stage rheumatoid arthritis in a mouse model.
Rheumatology contributors
-
Andrew D. Luster, MD, PhD
Chief of the Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Director of the Center for Immunology and Inflammatory Diseases
Recent Article
The Role of Atypical Chemoattractant Receptors in Recruiting Neutrophils into Inflamed Tissue Sites
-
Hak Soo Choi, PhD
Director, Bioengineering and Nanomedicine Program, Massachusetts General Hospital, Associate Professor of Radiology, Harvard Medical School, Faculty, Dana-Farber/Harvard Cancer Center
Recent Article
Tissue-Specific Contrast Agents for Optical Fluorescence to Evaluate Rheumatoid Arthritis -
John H. Stone, MD, MPH
Director, Clinical Rheumatology, Massachusetts General Hospital, Edward A. Fox Chair in Medicine at Mass General
Recent Article
First Classification Criteria Developed for IgG4–Related Disease
-
Yuqing Zhang, DSc
Director of Epidemiological and Biostatistical Methods, Rheumatology Unit, Massachusetts General Hospital, Professor in Residence in Medicine, Harvard Medical School
Recent Article
Cardiovascular Safety of Tramadol Not Assured for Osteoarthritis Patients -
Zachary S. Wallace, MD, MSc
Physician, Rheumatology Unit, Massachusetts General Hospital
Recent Article
Risk of Respiratory Failure Tripled in COVID-19 Patients with Existing Rheumatic Disease
Rheumatology
The Rheumatology Unit at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.
